LiteVax

Akkersestraat 50

4061Bj Ophemert

NL

LiteVax

Foundation date

24/05/2012

Sector

#Pharma

Subsector

Therapeutic areas

LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by delivering improved adjuvants for vaccines against infectious and noninfectious diseases. People in developed and developing countries will benefit from better vaccines at lower costs.

Upcoming events

Latest news

  • Mithra announces topline results for COVID-19 Phase II Study

    1 day ago

  • Biocartis announces restart of its high-throughput cartridge manufacturing line

    Thursday September 23rd 2021

  • Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer

    Wednesday September 22nd 2021